Cargando…
Discovery of Monoacylglycerol Lipase (MAGL) Inhibitors Based on a Pharmacophore-Guided Virtual Screening Study
Monoacylglycerol lipase (MAGL) is an important enzyme of the endocannabinoid system that catalyzes the degradation of the major endocannabinoid 2-arachidonoylglycerol (2-AG). MAGL is associated with pathological conditions such as pain, inflammation and neurodegenerative diseases like Parkinson’s an...
Autores principales: | Jha, Vibhu, Biagi, Marzia, Spinelli, Valeria, Di Stefano, Miriana, Macchia, Marco, Minutolo, Filippo, Granchi, Carlotta, Poli, Giulio, Tuccinardi, Tiziano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794939/ https://www.ncbi.nlm.nih.gov/pubmed/33375358 http://dx.doi.org/10.3390/molecules26010078 |
Ejemplares similares
-
Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors
por: Poli, Giulio, et al.
Publicado: (2019) -
Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors
por: Granchi, Carlotta, et al.
Publicado: (2017) -
Reversible Monoacylglycerol
Lipase Inhibitors: Discovery
of a New Class of Benzylpiperidine Derivatives
por: Bononi, Giulia, et al.
Publicado: (2022) -
New PIN1 inhibitors identified through a pharmacophore-driven, hierarchical consensus docking strategy
por: Poli, Giulio, et al.
Publicado: (2021) -
Monoacylglycerol Lipase (MAGL) Inhibition Attenuates Acute Lung Injury in Mice
por: Costola-de-Souza, Carolina, et al.
Publicado: (2013)